Neurology Minute

In part one of this nine-part series, Dr. Christine Cliatt-Brown provides an overview of delusional misidentification syndromes.

In the final episode of this series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the complex role of TNF alpha inhibition in tuberculosis treatment and the use of infliximab and other targeted therapies to manage inflammation.

In this episode, Dr. Jose Posas reviews the Capitol Hill Report from September 7th, discussing the busy month ahead for Congress, BrainPAC, and a couple of other advocacy news items. 
Stay updated with what's happening on the hill by visiting aan.com/chr. 
Learn how you can get involved with AAN advocacy.

In part two of this series, Dr. Aaron Zelikovich and Dr. Bhaskar Roy discuss recommendations to help neurologists navigate the expanding landscape of myasthenia gravis treatments. 
Show citation: 
McLaren NP, Rosati M, Zhong W, et al. Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments: A Bayesian Network Meta-Analysis. Neurology. 2026;107(3):e218351. doi:10.1212/WNL.0000000000218351

In the second episode of this series, Dr. Justin Abbatemarco and Dr. Sara Marceglia discuss the risks of incorporating AI into clinical practice. 
Show citation: 
Vozzi C, Sibilla M, Sandri D, et al. Education Research: Bridging the Artificial Intelligence Training Gap: Evidence from a National Survey of Italian Neurology Residents. Neurol Educ. 2026;5(1):e200289. Published 2026 Jan 27. doi:10.1212/NE9.0000000000200289